Overview Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis Status: Recruiting Trial end date: 2023-05-01 Target enrollment: Participant gender: Summary This is a Phase 2a safety and efficacy study of EVO101 for the treatment of adults with atopic dermatitis Phase: Phase 2 Details Lead Sponsor: Evommune, Inc.